139 related articles for article (PubMed ID: 26781461)
1. Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells.
Eskandari N; Tashrifi F; Bastan R; Andalib A; Yousefi Z; Peachell PT
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):654-665. PubMed ID: 26781461
[TBL] [Abstract][Full Text] [Related]
2. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
3. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
Richter W; Jin SL; Conti M
Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
5. Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium.
Leroy MJ; Méhats C; Duc-Goiran P; Tanguy G; Robert B; Dallot E; Mignot TM; Grangé G; Ferré F
Cell Signal; 1999 Jan; 11(1):31-7. PubMed ID: 10206342
[TBL] [Abstract][Full Text] [Related]
6. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ
Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419
[TBL] [Abstract][Full Text] [Related]
7. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
[TBL] [Abstract][Full Text] [Related]
8. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
Kostic MM; Erdogan S; Rena G; Borchert G; Hoch B; Bartel S; Scotland G; Huston E; Houslay MD; Krause EG
J Mol Cell Cardiol; 1997 Nov; 29(11):3135-46. PubMed ID: 9405187
[TBL] [Abstract][Full Text] [Related]
10. Expression of mRNA encoding cAMP-specific phosphodiesterase isoforms in rat parotid glands.
Imai A; Nashida T; Shimomura H
Biochem Mol Biol Int; 1996 Dec; 40(6):1175-81. PubMed ID: 8988329
[TBL] [Abstract][Full Text] [Related]
11. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
Manning CD; McLaughlin MM; Livi GP; Cieslinski LB; Torphy TJ; Barnette MS
J Pharmacol Exp Ther; 1996 Feb; 276(2):810-8. PubMed ID: 8632354
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro.
Wang H; Edens NK
J Lipid Res; 2007 May; 48(5):1099-107. PubMed ID: 17267946
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
14. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
[TBL] [Abstract][Full Text] [Related]
15. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases.
Baillie GS; MacKenzie SJ; McPhee I; Houslay MD
Br J Pharmacol; 2000 Oct; 131(4):811-9. PubMed ID: 11030732
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
Bartsch O; Bartlick B; Ivell R
J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
[TBL] [Abstract][Full Text] [Related]
18. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
Levallet G; Levallet J; Bouraïma-Lelong H; Bonnamy PJ
Biol Reprod; 2007 May; 76(5):794-803. PubMed ID: 17215491
[TBL] [Abstract][Full Text] [Related]
19. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
